Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

AGEN 5.03 -0.19 (-3.64%)
price chart
Why Shares of Agenus Inc Spiked
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Here Is Why Agenus Inc (NASDAQ:AGEN) Is Soaring  Bidness ETC
Agenus Inc. (AGEN) Surged To A New High After Incyte Agreement  RTT News
Agenus, Inc. - "2015: Poised To Be Another Transformative Year for Agenus"
Jan 12, 2015 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / January 12, 2015 / Agenus, Inc. AGEN, -2.30% today published a new blog post on The Chairman's Blog, written by the Company's Chairman and CEO, Dr.
Agenus Inc. Files SEC Form SC 13G, Statement of Acquisition of Beneficial ...
By a News Reporter-Staff News Editor at Biotech Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S.
Agenus (AGEN) Is Today's Dead Cat Bounce Stock
Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants.
Stocks Underperform for the Week: Western Digital Corp , Agenus Inc  Ashburn Daily
Healthcare Decliners of the Friday: CytRx (CYTR), Nanosphere, (NSPH), Juno ...  iStreetWire
Morning Buzz: NPS Pharmaceuticals (NPSP), Tekmira Pharmaceuticals (TKMR ...
Agenus Inc.'s (AGEN) stock popped 21% Monday following favorable commentary on Friday's Mad Money, and a price target raised at Maxim Group this morning.
Pharma M&A Keeps Getting Hotter With $7 Billion in Announced Deals  Wall Street Journal (blog)
Morning Buzz: Tekmira Pharmaceuticals Corp (NASDAQ:TKMR), NPS ...  Market News Call
Today's Perilous Reversal Stock: Agenus (AGEN)
Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants.
Agenus Inc (AGEN): QVT Financial Trims Its Passive Stake as It Gains Value
Daniel Gold's QVT Financial has reduced its stake in Agenus Inc (NASDAQ:AGEN) by around 2.34 million shares, as a filing with the Securities and Exchange Commission showed.
Agenus Inc Analyst Rating Update  Stafford Daily
Insider Selling: Agenus Inc (AGEN), Nike Inc (NKE), Gap Inc (GPS)  Bidness ETC
Short Interest of Agenus Inc Increases
Agenus Inc (NASDAQ:AGEN) has shown a rise of 0.5% or 26,498 shares in the short positions. The bets have increased to 5,443,413 shares on December 31,2014 from 5,416,915 shares on December 15,2014.
Agenus Inc Discloses Insider Transaction  Wall Street Pulse
Agenus major shareholder Sells $12444675.30 in Stock (AGEN)  Ticker Report
Agenus Inc. (AGEN) Jumps 5.85% on January 26
Agenus Inc. ($AGEN) was among the biggest gainers on the Russell 2000 for Monday January 26 as the stock popped 5.85% to $5.25, representing a gain of $0.29 per share.
Short Interest of Agenus Inc Increases by 10.7%
Agenus Inc (NASDAQ:AGEN) has shown a rise of 10.7% or 582,902 shares in the short positions. The bets have increased to 6,026,315 shares on January 15,2015 from 5,443,413 shares on December 31,2014.